Development of CP506 a novel hypoxia-selective cytotoxin for the treatment of triple negative breast cancer (TNBC)

Show simple item record

dc.contributor.advisor Abbattista, M en
dc.contributor.advisor Patterson, A en
dc.contributor.advisor Guise, C en
dc.contributor.author Moore, Sarah en
dc.date.accessioned 2019-11-20T22:37:13Z en
dc.date.issued 2019 en
dc.identifier.uri http://hdl.handle.net/2292/48966 en
dc.description Thesis embargoed until 11/2021. en
dc.publisher ResearchSpace@Auckland en
dc.relation.ispartof Masters Thesis - University of Auckland en
dc.relation.isreferencedby UoA99265329914102091 en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights Restricted Item. Full Text is available to authenticated members of The University of Auckland only. en
dc.rights Restricted Item. Thesis embargoed until 11/2021. Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.title Development of CP506 a novel hypoxia-selective cytotoxin for the treatment of triple negative breast cancer (TNBC) en
dc.type Thesis en
thesis.degree.discipline Biomedical Science en
thesis.degree.grantor The University of Auckland en
thesis.degree.level Masters en
dc.rights.holder Copyright: The author en
dc.rights.accessrights http://purl.org/eprint/accessRights/ClosedAccess en
pubs.elements-id 786514 en
pubs.record-created-at-source-date 2019-11-21 en


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics